{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:06:44Z","timestamp":1648926404275},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2016,5,19]]},"DOI":"10.2174\/1389450116666150907105306","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T05:16:20Z","timestamp":1464671780000},"page":"1072-1082","source":"Crossref","is-referenced-by-count":4,"title":["Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art"],"prefix":"10.2174","volume":"17","author":[{"given":"Magdalena","family":"Witkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Smolewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/134725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T10:45:14Z","timestamp":1493721914000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1389-4501&volume=17&issue=9&spage=1072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,5,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450116666150907105306","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,19]]}}}